Stroke is a serious, life-threatening condition demanding vigorous search for new therapies.
Recent research has focused on stem cell-based therapies as a viable choice following ischemic stroke,
based on studies displaying that stem cells transplanted to the brain not only survive but also cause
functional recovery. Growth factors defined as polypeptides that regulate the growth and differentiation
of many cell types. Many studies have demonstrated that combined use of growth factors may increase
results by the stimulation of endogenous neurogenesis, anti-inflammatory, neuroprotection
properties, and enhancement of stem cell survival rates and so may be more effective than a single
stem cell therapy. This paper reviews and discusses the most promising new stroke recovery research,
including combination treatment.